Author:
Wachsmuth Ernst D.,Huber Juergen
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Allison AC, Wachsmuth ED (1986) MDP and derivatives II. In: Chedid L, Hadden JW, Spreafico F, Dukor P, Willoughby D (eds) Advances in immunopharmacology 3. Pergamon Press, London, pp 479–485
2. Braun DG, Dukor P, Lukas B, Schumann G, Tarsay L, Court M, Schaffner JC, Skripsky T, Fischer M, Graepel P (1987) MTP-PE, a synthetic lipophilic muramyltripeptide, biological and toxicological properties. In: Berlin A, Dean J, Draper H, Smith EMB, Spreafico F (eds) Immunotoxicology. Martinus Nijhoff Publ, Dordrecht, pp 219–233
3. Brownbill AF, Braun DG, Dukor P, Schumann G (1985) Induction of tumouricidal leucocytes by the intranasal application of MTP-PE, a lipophilic muramyl dipeptide. Cancer Immunol Immunother 20:11–17
4. Broudy VC, Kaushansky K, Adamson JW (1988) Muramyl dipeptide (MDP) induced hematopoetic growth factor production in vivo by a mechanism independent of tumor necrosis factor (TNF). Clin Res 36:406 A
5. Dietrich FM, Hochkeppel HK, Lukas B (1986) Enhancement of host resistance against virus infections by MTP-PE, a synthetic muramyl peptide. I. Increased survival in mice and guinea pigs after a single drug administration prior to infection, and the effect of MTP-PE on interferon levels in sera and lungs. Int J Immunopharmacol 8:931–942
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献